TGF-β plays an important role in the etiology on MM, and the MM bone marrow tumor microenvironment is TGF-β-rich, owing to both production of this cytokine by the MM cells, and by stromal cells, fibroblasts and osteoblasts in the resorpted bone marrow (15–17). Here, TGFB1 is linked to Miyoshi myopathy.